English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: A systematic review and meta-analysis Journal article
He L., Liu S., Shan C., Tu Y., Li Z., Zhang X.D.. Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: A systematic review and meta-analysis[J]. BMC Pharmacology and Toxicology, 2016, 17(1).
Authors:  He L.;  Liu S.;  Shan C.;  Tu Y.;  Li Z.; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5 | Submit date：2018/12/21
Diabetes Mellitus  Differential Hba1c Response  Dipeptidyl Peptidase-4 Inhibitor  Meta-analysis  T2dm  
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Other
2016-01-01
Authors:  Klionsky, Daniel J.;  Abdelmohsen, Kotb;  Abe, Akihisa;  Abedin, Md Joynal;  Abeliovich, Hagai; et al.
Favorite | TC[WOS]:407 TC[Scopus]:24 | Submit date：2022/07/20
NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth Journal article
Zha X., Hu Z., Ji S., Jin F., Jiang K., Li C., Zhao P., Tu Z., Chen X., Di L., Zhou H., Zhang H.. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth[J]. Cancer Letters, 2015, 359(1), 97-106.
Authors:  Zha X.;  Hu Z.;  Ji S.;  Jin F.;  Jiang K.; et al.
Favorite | TC[WOS]:49 TC[Scopus]:50 | Submit date：2018/12/21
Aerobic Glycolysis  Glut3  Mtor  Nfκb  Tumorigenesis